Volver a Agenda
Session Chair(s)
Yeh-Fong Chen, PHD
Mathematical Statistician (Team Lead), Office of Translational Sciences, CDER
Food and Drug Administration, United States
Learning Objective : Articulate potential issues in designing a multiregional clinical trial; Devise solutions applicable to sample size planning for trials with potential inhomogeneous treatment effects across regions.
Speaker(s)
Statistical Considerations in Planning Sample Size for MRCT
H. M. James Hung, PHD
FDA, United States
Director, Division of Biometrics I, Office of Biostatistics, OTS, CDER
Optimal Designs for Multiregional Clinical Trials with an Additional Regional Requirement
Zhaoyang Teng, MA
Boston University, United States
PhD Candidate, Biostatistics
Discussion from Industry Perspective
Gordon Lan, PHD
Janssen R&D, LLC, United States
Senior Scientific Director
¿Tiene una cuenta?